Skip to main content
BioDefense Pro

BioDefense Pro

A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.

BiotechCambridge

About BioDefense Pro

BioDefense Pro is a Cambridge-based biotechnology company operating in the biodefense and biosecurity sector. Based on its name and location in the prominent biotech hub of Cambridge, the company likely focuses on developing countermeasures against biological threats, which could include vaccines, therapeutics, or diagnostic tools for biodefense applications.

The company has raised $11 million in seed funding, indicating it is in the early stages of development but has attracted initial investor interest in its biodefense technologies. The biodefense market has seen increased attention from both government and private investors, particularly given growing concerns about biological threats and pandemic preparedness. As an active company in this critical sector, BioDefense Pro appears positioned to address national security and public health challenges through biotechnology solutions.

Funding History (1 round)

DateRoundAmountLead Investor
Feb 2026Seed$11MRA Capital Management

Frequently Asked Questions

What does BioDefense Pro do?

A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.

How much funding has BioDefense Pro raised?

BioDefense Pro has raised $11M in total funding, with their most recent round being a Seed. The company operates in the Biotech sector.

What sector is BioDefense Pro in?

BioDefense Pro operates in the Biotech sector. A Cambridge-based biotech company developing biotechnology solutions for biodefense and biosecurity applications.

Sponsored
AArchstone

The operating system for private capital.

Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.

LP portalCapital calls$297/moNo AUM fees
Book a demo

Company Details

Sector
Biotech
Headquarters
Cambridge
Status
Active
Last Funding Stage
Seed
Total Funding
$11M

Related Biotech Companies